David Dodwell

BSc, MD, FRCP, FRCR

Senior Clinical Research Fellow

I am a senior breast oncologist based in Leeds with a number of research and governance activities. I am the lead oncologist on the Sloane, NHS screening & national HQIP breast cancer audits.

I am a senior clinical research fellow to the EBCTCG and a member of steering groups for 12 ongoing UK trials in breast cancer. I sit on the trial management committees for 3 trials.

I am UK lead for the SACT project (UK chemotherapy database) and chair the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England.

Recent publications

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
Journal article

Thompson AM. et al, (2018), Eur J Cancer, 101, 210 - 219
Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?
Journal article

Bagenal J. et al, (2018), BMJ, 361
Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Journal article

Maxwell AJ. et al, (2018), Eur J Surg Oncol, 44, 429 - 435
Neoadjuvant chemotherapy for early breast cancer - Author's reply.
Journal article

McGale P. et al, (2018), Lancet Oncol, 19
Impact of radiotherapy and endocrine therapy on further events: Final multivariate analysis of a prospective, national cohort study of screen detected ductal carcinoma in situ (DCIS) of the breast
Conference paper

Thompson AM. et al, (2018), CANCER RESEARCH, 78

More publications